Press Releases

Samsung BIO Insight

Samsung Biologics builds stronger connections through bolstered CDO capabilities and continuous expansion | Highlights from BIO 2024

Banners installed on Harbor Drive


Samsung Biologics made a scene at the 2024 BIO International Convention held between June 3-6 in San Diego. The company shared updates on its strengthened CDO capabilities and developments regarding capacity expansion and portfolio diversification. The Samsung Biologics team was also able to network with existing and potential clients throughout the four-day event.


The Samsung Biologics team greets visitors at its booth


At its eye-catching booth, Samsung Biologics showcased its client-centric service value – Agile. Flexible. Focused on You. – reflecting the company’s commitment to offer tailored and seamless solutions with accelerated timelines for its clients. Samsung Biologics introduced S-TensifyTM – the latest addition to its series of proprietary technology platforms. It is an intensified cell culture platform designed to support the development of high-concentration biopharmaceuticals.


The company also shared updates regarding Plant 5 and its antibody-drug conjugate (ADC) facility. Plant 5, the first facility of Bio Campus II, will add fresh capacity of 180,000 liters when operational in April 2025 – giving Samsung Biologics a total biomanufacturing capacity of 784,000 liters. The construction of the company’s ADC facility is also expected to be complete by the end of the year.


Samsung Biologics’ booth also had private space to facilitate meetings with existing and potential clients to learn more about the company’s offerings and discuss collaboration opportunities in manufacturing and development.


Samsung Biologics’ booth attracts visitors at BIO 2024


Private lounge located within Samsung Biologics’ booth to facilitate client meetings


Corporate brochures downloadable via QR codes as part of sustainability efforts


Samsung Biologics’ CEO and President John Rim held a press conference to share the company’s growth plans and strategies, as well as industry developments. The company’s senior executives also actively engaged with visitors and reporters.


John Rim, CEO and President, meets with reporters to share business growth plans


Brian Min, Executive Vice President and Head of CDO Center, holds press conference


James Choi, Executive Vice President and Head of Sales Support, gives booth tour


Kevin Sharp, Senior Vice President and Head of Sales, takes part in BPI Theater


The company also made an impact within the exhibition center and the roads of San Diego, with its vibrant banners and displays.


Samsung Biologics’ banners displayed across the exhibition center


Over 140 banners installed on main street leading from San Diego Airport to the exhibition center


Samsung Biologics thanks everyone that connected during BIO 2024 to build new relations and explore partnership opportunities. If you would like to find out more about our agile and flexible services or meet with our experts, please visit our website: www.samsungbiologics.com


We are here to support your program!

 



Related Content

News Brief Samsung Biologics to attend 2024 BIO International Convention

Samsung BIO Insight Agile. Flexible. Focused on You.

Banners installed on Harbor Drive


Samsung Biologics made a scene at the 2024 BIO International Convention held between June 3-6 in San Diego. The company shared updates on its strengthened CDO capabilities and developments regarding capacity expansion and portfolio diversification. The Samsung Biologics team was also able to network with existing and potential clients throughout the four-day event.


The Samsung Biologics team greets visitors at its booth


At its eye-catching booth, Samsung Biologics showcased its client-centric service value – Agile. Flexible. Focused on You. – reflecting the company’s commitment to offer tailored and seamless solutions with accelerated timelines for its clients. Samsung Biologics introduced S-TensifyTM – the latest addition to its series of proprietary technology platforms. It is an intensified cell culture platform designed to support the development of high-concentration biopharmaceuticals.


The company also shared updates regarding Plant 5 and its antibody-drug conjugate (ADC) facility. Plant 5, the first facility of Bio Campus II, will add fresh capacity of 180,000 liters when operational in April 2025 – giving Samsung Biologics a total biomanufacturing capacity of 784,000 liters. The construction of the company’s ADC facility is also expected to be complete by the end of the year.


Samsung Biologics’ booth also had private space to facilitate meetings with existing and potential clients to learn more about the company’s offerings and discuss collaboration opportunities in manufacturing and development.


Samsung Biologics’ booth attracts visitors at BIO 2024


Private lounge located within Samsung Biologics’ booth to facilitate client meetings



Corporate brochures downloadable via QR codes as part of sustainability efforts


Samsung Biologics’ CEO and President John Rim held a press conference to share the company’s growth plans and strategies, as well as industry developments. The company’s senior executives also actively engaged with visitors and reporters.


John Rim, CEO and President, meets with reporters to share business growth plans


Brian Min, Executive Vice President and Head of CDO Center, holds press conference


James Choi, Executive Vice President and Head of Sales Support, gives booth tour


Kevin Sharp, Senior Vice President and Head of Sales, takes part in BPI Theater


The company also made an impact within the exhibition center and the roads of San Diego, with its vibrant banners and displays.


Samsung Biologics’ banners displayed across the exhibition center


Over 140 banners installed on main street leading from San Diego Airport to the exhibition center


Samsung Biologics thanks everyone that connected during BIO 2024 to build new relations and explore partnership opportunities. If you would like to find out more about our agile and flexible services or meet with our experts, please visit our website: www.samsungbiologics.com


We are here to support your program!

 


Related Content

News Brief Samsung Biologics to attend 2024 BIO International Convention

Samsung BIO Insight Agile. Flexible. Focused on You.

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION